HIV neuropathogenesis and therapeutic strategies

Pediatrics International

Volumn 40, Issue 2, 1998, Pages 107-111

  Epstein, Leon G ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; Human immunodeficiency virus; Neuroprotection; Pathogenesis

Indexed keywords

AMPA RECEPTOR; ANTIRETROVIRUS AGENT; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE ACTIVATION; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; VIRUS PATHOGENESIS;

AIDS DEMENTIA COMPLEX; APOPTOSIS; BLOOD-BRAIN BARRIER; HIV-1; HUMANS;

EID: 0031977848     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1998.tb01892.x     Document Type: Article

References (37)

1. Janssen Rs. Cornblath Dr. Epstein Lg et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 778–85.
2. Epstein Lg. Sharer Lr. Oleske Jm et al. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 1986: 78: 678–87.
3. Aylward Eh. Henderer Jd, Mcarthur Jc et al Reduced basal ganglia volume in HIV-1-associated dementia: Results from quantitative neuroimaging. Neurology 1993; 43: 2099–104.
4. Sharer Lr. Pathology of HIV-1 infection of the central nervous svstem: A review. J. Neuropathol. E.xp. Neurol. 1992; 51:3–11.
5. Saito Y. Sharer Lr. Epstein Lg et al. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in post-mortem pediatric central nervous tissue. Neurology 1994: 44: 474–81.
6. Tornatore C. Chandra R. Berger J., Major E. HIV-1 infection of subcortical astrocytes in pediatric central nervous system. Neurology 1994:44: 481–7.
7. Wiley Ca. Masliah E. Morey M. et al. Neocortical damage during HIV infection. Ann. Neurol. 1991; 29: 651–7.
8. Weis S. Haug H. Budka H. Neuronal damage in the cerebral cortex of AIDS brains: A morphometric study. Acta Neuropathol. 1993:85: 185–9.
9. Everall I., Luthert P. Lantos P. A review of neuronal damage in human immunodeficiency virus infection: Its assessment, possible mechanism and relationship to dementia. J. Neuropathol. Exp. Neurol. 1993: 52: 561–6.
10. Gelbard Ha. James Hj. Sharer Lr et al. Identification of apoptotic neurons in post-mortem brain tissue from pediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 1995: 21: 208–17.
11. Glass Jd. Fedor H., Wesselingh Sl, Mcarthur Jc. Immuno-cytoehemical quantitation of human immunodeficiency virus in the brain. Ann. Neurol. 1995; 38: 755–62.
12. Genis P., Jett M., Bernton Ew et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV (-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J. Exp. Med. 1992:176: 1703–18.
13. Giulian D., Vaca K., Noonan Ca. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250: 1593–6.
14. Pulliam L. Herndier BG, Tang NM, McGrath MS. HIV-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 1991; 87: 503–12.
15. Gelbard Ha, Dzenko K., Diloreto D., Delccrro C., Delcerro M., Epstein Lg. Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: Implications for AIDS neuropathogenesis. Dev. Neurosci. 1994; 15: 418–22.
16. Gelbard Ha, Nottet Hslm, Swindells S. et al. Platelet activating factor: A candidate HIV-1-induced neurotoxin. J. Virol. 1994; 68: 4628–35.
17. Power C., Kong Pa, Crawford To et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann. Neurol. 1993; 34: 339–50.
18. Epstein Lg, Gendelman He. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms. Ann. Neurol. 1993: 33: 429–36.
19. Michaels J., Sharer Lr, Epstein Lg. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: A review. Immunodefic. Rev. 1988; 1: 42–77.
20. Sharer Lr, Michaels J., Murphey-Corb M., Hu Fs, Kuebler Dj, Martin Ln. Serial pathogenesis study of SIV brain infection. J. Med. Primatol. 1991; 20: 211–17.
21. Takahashi K., Wesselingh Sl, Griffin De, Mcarthur Jc, Johnson Rt, Glass Jd. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 1996; 39: 705–11.
22. Wesselingh Sl, Power C., Glass Jd et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 1993; 33: 576–82.
23. Lipton Sa. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp 120. Neuroreport 1992; 3: 913–15.
24. Albin Rl, Greenamyre Jt. Alternative excitotoxic hypotheses. Neurology 1992; 42: 733–8.
25. Clark Gd, Happel Lt, Zorumski Cf, Bazan Ng. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 1992; 9: 1211–16.
26. Fine Sm, Angel Ra, Perry Sw, Epstein Lg, Dewhurst S., Gelbard Ha. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes: Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 1996; 271: 15 303–6.
27. Volterra A., Troti D., Cassutti P., Tromba C., Salvaggio A., Melcangi Rc. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J. Neurochem. 1992; 59: 600–6.
28. Blumberg Bm, Gelbard Ha, Epstein Lg. HIV-1 infection of the developing nervous system: Central role of the astrocyte in pathogenesis. Virus Res. 1994; 32: 253–67.
29. Dawson Vl, Dawson Tm, Uhl Gr, Snyder Sh. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical neurons. Proc. Natl Acad. Sci. USA 1993; 90: 3256–9.
30. Talley Ak, Dewhurst S., Perry S. et al. Tumor necrosis factor α-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crm A.Mol. Cell. Biol. 1995; 15: 2359–66.
31. Adle-Biassette H., Levy Y., Colombel M. et al. Neuronal HIV neuropathogenesis 111 apoptosis in HIV infection in adults. Neuropathul. Appl. Neumbiol. 1995;21: 218–27.
32. Petito Ck, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 1995; 146: 1121–30.
33. Dollard Sc, James Hj, Sharer Lr, Epstein Lg, Gelbard Hg, Dewhurst S. Activation of nuclear factor KB in brains from children with HIV-1 encephalitis. Neuropathol. Appl. Neumbiol. 1995;21: 518–28.
34. Connor Em, Sperling Rs, Gelber R. et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 1994; 331: 1173–80.
35. Tsai Cc, Follis Ke, Sabo A. et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmefhoxypropyl) adenine. Science 1995; 270: 1197–9.
36. Pollack H., Kuchuk A., Cowan L. et al. Neurodevelopment, growth, and viral load in HIV-infected infants. Brain Behav. Immun. 1996; 10: 298–312.
37. Epstein Lg. Pediatrics 1986; 78: 678.